Corporations are responsible for all the actions of their employees ?

Utah nursing home must pay entire $1.4M jury award in death of patient who was given the wrong medicine, appeals court rules

https://www.sltrib.com/news/2018/02/02/utah-nursing-home-must-pay-entire-14m-jury-award-in-death-of-patient-who-was-given-the-wrong-medicine-appeal-court-rules/

When a jury decided three years ago that a Utah care facility should pay nearly $1 million to the family of a patient who died after a nurse mistakenly gave him the wrong medicine and then concealed her error until it was too late to save him, both parties in a wrongful-death suit were unhappy with the verdict.

Jurors determined that the nurse was not acting in the course and scope of her employment when she hid her mistake and therefore, Provo Rehabilitation and Nursing was not vicariously liable for the concealment. The jury allocated 65 percent of the fault for patient Jack Adams’ death to the initial error and, as the nurse’s employer, the nursing home was ordered to pay $910,000 of the approximately $1.4 million damage award, plus court costs.

But lawyers for the man’s relatives contended that knowledge of the concealment should be ascribed to Provo Rehab and that it should pay the full award.

On the other side, Provo Rehab’s attorneys argued the plaintiff had failed to produce sufficient evidence that the mistake itself — rather than the nurse’s concealment of the mistake — caused Adams’ death and that the trial judge should have entered a verdict in favor of the care facility.

Both parties appealed and now, the Utah Court of Appeals has sided with the family, ruling that Provo Rehab must pay the entire $1.4 million award.

In a 3-0 opinion handed down last month, the court noted that as with all corporations, Provo Rehab can act only through agents, be they officers or employees. Under the law, the general rule is that the knowledge of agents concerning the business they do for the employer is imputed to the employer, according to the decision.

So, the opinion says, all of the nurse’s knowledge that was material to her work for the nursing home, even facts she did not share with others, “is automatically imputed to Provo Rehab.” And the conclusion that the facility had constructive knowledge of the mistake means there could not have been concealment, the opinion says.

Writing for the court, Judge Ryan Harris said that in the absence of concealment, “we have no trouble concluding that the expert medical testimony presented at trial was more than sufficient to establish that the Medication Error was a proximate cause of Adams’s death.”

The now-former nurse, Camille W. Jensen, declared bankruptcy and was dismissed as a defendant after the jury verdict was returned in May 2015. She was not a party to the appeal.

The family’s attorney, Brad Parker, applauded the decision and compared the case to a situation where a grocery store employee sees a puddle of water on the floor. If the employee doesn’t tell the manager, that does not relieve the employer of liability if an innocent customer slips and falls, he said Friday.

Stephen Hester, an attorney who represents the nursing home, said Provo Rehab will appeal to the Utah Supreme Court. He said the concealment occurred outside the course and scope of the nurse’s employment, and that the concealment, not the error, caused the death.

“It eliminates an employer’s ability to defend itself in these circumstances” Hester said of the ruling, adding that an employer is entitled to defend itself when it has a rogue employee.

On Feb. 8, 2010, Jensen worked a six-hour swing shift as a licensed practical nurse at Provo Rehab. On a previous occasion, a narcotic pill ended up unaccounted for at the end of her shift and she had been told she would be fired if a similar incident ever occurred again, the opinion says.

At about 8 p.m., Jensen began a “medication pass,” walking down a hallway with a movable cart that held medicine she needed to administer. When she got to Adams’ room, the nurse made a crucial mistake: She mixed up his identity with that of another resident, the opinion says.

Jensen gave Adams three narcotics that had been prescribed to the other resident, according to the opinion.

A few minutes later, Jensen realized what she had done, and decided to conceal the mistake, the opinion says. She gave the other resident Adams’ less-potent medications and falsified medical records so they indicated both had been given the proper medicine.

Jensen later testified that at the time she did not think administering the incorrect medications would harm either man.

The nurse’s decision to hide what happened deprived Adams of an opportunity to be saved by the administration of another medication — known generically as naloxone — which will almost always reverse the effects of a narcotics overdose, the opinion says. The 71-year-old Spanish Fork resident was discovered not breathing the next morning and taken to a hospital, where he died two days later on Feb. 11, 2010.

The opinion says that at the time of his death, Adams had been at Provo Rehabilitation for 11 months for treatment for a number of medical conditions, including congestive heart failure and diabetes.

A retiree who had worked for Amoco, Adams enjoyed being with his family and tending to his roses, according to his obituary. He had celebrated his 50th wedding anniversary a few months prior to his death.

“Jack had a contagious laugh and was loved by all who knew him,” the obituary says. “He was a wonderful person with a honest integrity. He is known as a true gentleman and had a way of making everyone around him feel special.”

Jensen told her employer about the medication mistake after Adams’ funeral, according to a news release from the family’s attorney. Adams’ wife, Verlo Jean Adams, and daughter, Shaunna Lane, filed the wrongful-death suit in 4th District Court in December 2010. The widow died in 2011.

I am not sure what legal decisions set precedents and what won’t, but this is a interesting conclusion to a death that may have been caused by both a medical error – giving a pt the wrong medication – and the nurse covering up the error.  Does this have applications to health care corporations (insurance companies, hospitals ..etc..etc ) where the employee is following the corporation’s policies and procedures in regards to how many opiate a prescriber may give to a pt or prohibit the prescriber from providing opiates to any/all pts.

How this decision may impact the ability of pts and/or get the interest of law firms that wish to go after the “deep pockets” of these corporations for violating various discrimination laws and deterioration of the pt’s quality of life and/or inability to do many daily self-care functions that they were able to perform before their pain management meds were reduced or taken away.

chronic pain pts should share their pain when they have their meds cut off ?

eeeeHi Steve I saw an older post to send you info on pain management doctors cutting patients meds.  I was a pain patient with this office for 11 years Dr. Roger B. Stephens in Sacramento, Ca.  Dr. Stevens retired many years ago & the other doctors Dr.Kim & Dr.Leano took it over but the name remains on the door. Dr. Kim & Dr Leano both prescribed for me for the last 11 years I was considered a model patient never any problems ever in 11 years until recently. I was abandoned at my last monthly apt. looking back at how the visit played out & how it all went it was pointed out to me it was most likely planned to happen. Anyway I requested my sudden forced rapid taper they were ignoring the negative effects already happening to me I still was going to be forced to continue regardless of what happened to me. Per usual the excuse we always disagreed on was used & blamed on the CDC guidelines one size fits all dose excuse everyone was being taken down to & was being used to justify my medically unnecessary taper & torture no matter how much what they were doing was wrong & killing me even though they agreed with me repeatedly at many many many visits this shouldn’t be done & they used to fight to keep my meds no longer. My forced taper was was also blamed on the third party provider,  drug addicts, societies opinion & the CDC guidelines all were used as the reason for my pain meds being forced to reduce against my will & my families wishes all was ignored & finally at my last apt. I was released after asking for a temp stall in tapering or at least a slow down on the dose amount of the tapering asking why I suddenly went from tapering by only one 30 mg. tablet a month to now I was to be reduced by 80 % to almost 90% of medications I took for 2 decades successfully. I never was given an answer except for the third party provider doctor said so & had dictated I had to be reduced rapidly in just 3 to 4 months down to the CDC max. dose no changes it was in stone . I had been slowly tapering for almost a year after a forced med change & severe dose reduction I had been reducing by 1 30 mg tablet a month & then suddenly it was to be all done in just weeks without any explanation why it must be sped up I was truly afraid for my life that this would kill me. I was terrified to be returned to pain I hadn’t felt without pain relief in 20 years & didn’t think I or my body would survive it.  To be returned to basically no effective meds & all that pain was going to be even worse then ever before because now I know the benefits of pain being relieved & was so afraid I wouldn’t survive my body would fail or I wouldn’t be able to cope with it.  So anyway she gave me my 30 day script a one sentence letter saying we didn’t agree on my treatment so she wouldn’t treat me any longer & she also gave me list of other pain doctors in the area. The same doctors she had spent the last year threatening me with them that they would treaty me worse then her when she would justify her actions and cancelled my apts. & would not see me again.

 

This is a post that I made over 2 yrs ago... https://www.pharmaciststeve.com/?p=12615 

When a pt has their meds reduced or stopped generally they move from just being “handicapped pt” to a “non-functioning handicapped person” and the whole family suffers from the action of the prescriber.  This posts deals with the potential consequences for the prescriber for the harm done to “the family” the last thing that the prescriber would be expecting is to be sued by the family for loss of companionship…

 

Derek Morrison’s CIAA Vigil in Washington, D.C. ~ August 2017 440 views

https://youtu.be/cbbYH-uiPO4

Who is going to be sued because pts didn’t get a flu shot and got the flu ? Excessive expense on the system ?

Influenza Hospitalizations Highest on Record, CDC Says

https://www.medscape.com/viewarticle/892240

Overall hospitalizations for influenza-like illness (ILI) are at their highest since the US Centers for Disease Control and Prevention (CDC) began collecting such data, according to new information presented during a teleconference by the CDC today.

“In the past week, we have seen increased [ILI] activity, more hospitalizations, and tragically, more flu-associated deaths in children and adults,” Anne Schuchat, MD, RADM, USPHS, and acting director, CDC, said. “As of this week, overall hospitalizations are now the highest we’ve seen, even higher than in 2014-2015, our previous high season.”

Reports of crowded hospitals and spot shortages of antiviral drugs and rapid influenza tests continue. “Unfortunately, our latest tracking data indicate that flu activity is still high and widespread across most of the nation,” Dr Schuchat added.

Unusual Pattern

“”[T]his season is turning out to be a particularly challenging one, and it has been compounded by lots of flu occurring nationwide simultaneously over several weeks,” said Dan Jernigan, MD, MPH, CAPT, USPHS, director, Influenza Division, National Center for Immunization and Respiratory Diseases. “This is an unusual pattern for flu in the [United States].”

 

For the 3 weeks prior to the current week, influenza activity was widespread in 49 states — something that has not occurred since the CDC began collecting influenza activity data. That number fell to 48 states this week, with Oregon and Hawaii reporting decreased activity.

The percentage of patients seen in physicians’ offices, urgent care clinics, and emergency departments for ILI increased again this week, going from 6.6% last week to 7.1% this week. For two seasons during the past 16 years rates, have been higher than that — the 2009 H1N1 pandemic peaked at 7.7%, and the 2003-2004 season, which was a high-severity H3N2 season, peaked at 7.6%, Dr Jernigan explained.

The level of ILI activity has been elevated for 10 consecutive weeks. During the past five seasons, the average duration of an influenza season has been 16 weeks, ranging from 11 to 20 weeks. “There may be many weeks left for this season to go,” Dr Jernigan said.

The number of states that reported high ILI activity this week rose from 39 to 42. In the western states, activity is starting to decrease, the eastern part of the country is seeing higher activity, and southern states continue to report high activity, with levels similar to those of previous weeks.

“For the second week in a row, there are signs that activity in the West may be easing up. However, we are by no means out of the woods. Most seasons last up to 20 weeks, and we’ve probably got several weeks left of increased flu activity,” Dr Schuchat explained.

High-Severity Season

The CDC collects information about laboratory-confirmed influenza hospitalizations in 13 states, which represent a population of approximately 9% of the United States. During the past few weeks, hospitalizations have tracked closely with the 2014-2015 season, which was described as representing high severity, with an estimated 710,000 hospitalizations during the season.

The CDC reports that for this week, the cumulative hospitalization rate was 51.4 per 100,000, which is higher than the 43.5 per 100,000 reported at this same week during the 2014-2015 season. If that trend continues through the season, the number of influenza hospitalizations may exceed 710,000. The highest hospitalization rates are among those aged 65 years and older, followed by individuals aged 50 to 64 years and children younger than 5 years.

 

Hospitalization rates continue to be significantly higher in some states. Although rates were lower during the past week, cumulative hospitalization rates in California were approximately four times higher than during 2014-2015, and rates were double for that period in Oregon and Minnesota.

 

In adults, the number of deaths from pneumonia and influenza also increased during the past week, from 9.1% to 9.7%. “This is not as high as during seasons 2012-2013 and 2014-2015, where they peaked at 11.1% and 10.8%, but it is possible that this season will reach or surpass those two severe seasons,” Dr Jernigan said.

 

Most (76%) of the 45,000 respiratory specimens tested in state public health laboratories this season are influenza A (H3N2), although influenza A (H1N1) and influenza B viruses are also circulating.

 

Among H3N2 viruses evaluated by the CDC and five other World Health Organization–designated laboratories, there is no evidence that the virus has significantly drifted; however, viruses that have been prepared for use in vaccines “have adaptations that make them less similar to the circulating H3N2 viruses,” Dr Jernigan explained.

 

Children Particularly Hard-hit

Pediatric deaths from influenza are the highest since 2014-2015. An additional 16 influenza-related pediatric deaths were reported this week, totaling 53 children this season.

 

Of the children who died from influenza, only about 20% were vaccinated, and half were otherwise healthy.

 

Hospitalizations among children are tracking lower than during the 2014-2015 season, although it is too soon to know how many such hospitalizations will occur by the end of the season.

 

Dr Schuchat urged parents of children to call their primary care provider or a nurse hotline before taking their child to the doctor or emergency department. “In general, worrisome signs are very high, persisting fever, difficulty breathing or shortness of breath, rapid heartbeat or shallow, rapid breathing, or significant tiredness or confusion. In very young children, those kinds of symptoms are going to be difficult to assess, and so we really do think that a call to the pediatrician or nurse hotline is very important,” she explained.

 

When seeking medical care at the clinic or hospital, parents should cover the child’s mouth with a mask if the child is coughing.

 

A red flag for children and adults alike is an individual’s showing signs of improvement, and then suddenly becoming worse. That can indicate the development of a secondary bacterial pneumonia, which could be a “bad emergency,” Dr Schuchat said.

 

Concerns About Flu Shot Effectiveness This Year

There are ongoing concerns about the vaccine’s effectiveness.

 

Dr Schuchat said the CDC is concerned that the current vaccine’s effectiveness against H3N2 viruses “is lower than against other types and that in recent years, it’s been more challenging to even get effective H3N2 protection,” she explained.

 

She said the CDC recommends the influenza vaccine, “even though we know that most vaccines have low effectiveness against H3N2 viruses.” Effectiveness is better against other influenza viruses, and there is more than one circulating influenza virus. The vaccine may also reduce the severity of symptoms in those who develop influenza. It is not too late to get vaccinated, she added.

 

Bacterial pneumonia can be a serious complication of influenza, and viral infections such as influenza can make individuals more susceptible to secondary bacterial infections. Individuals who appear to be getting better and suddenly worsen should seek medical attention.

 

Pneumococcal pneumonia is a common culprit in secondary bacterial pneumonias, and the CDC recommends vaccination against pneumococcal pneumonia for those aged 65 years and older.

Indiana House BIll 1175 – SUGAR the next CONTROLLED SUBSTANCE ?

See the source image

DIGEST

Diabetes reporting. Requires the state department of health (state department) to collaborate with the office of the secretary of family and social services and

develop a strategic plan to identify and significantly reduce the prevalence of diabetes and prediabetes.

Requires the state department to establish workgroups to assist with development of the strategic plan. Requires the state department to submit the strategic plan to the governor and the general assembly and to update the strategic plan every two years until July 1, 2026.

Who is going to be held responsible for pts not taking their chronic medication ?

Nebraska first state to require all drugs reported to PDMP

http://www.healthcareitnews.com/news/nebraska-becomes-first-state-require-all-drugs-be-reported-prescription-monitoring-program

Nebraska Health Information Initiative CEO Deb Bass said the agency is trying to identify and avoid adverse medical effects to reduce readmissions.

Nebraska is the first state to require reporting of all dispensed prescription drugs to the Prescription Drug Monitoring Program.

Nebraska Health Information Initiative CEO Deb Bass said the move could save lives – not only for those taking opioids, but potentially for anyone prescribed drugs.

“We’re after those adverse medical effects,” Bass said. “Often readmissions are connected to improper medication usage, or

they didn’t get their medications filled. They didn’t take the medication as they were supposed to.

There are also individuals that have drug-drug interaction and they end up being re-hospitalized.”

The PDMP nationwide initiative took effect Jan. 1, 2018, and other states have also been advancing their health IT efforts to support drug monitoring.

The Indiana Scheduled Prescription Electronic Collection and Tracking program, or INSPECT, is compiling controlled substance information into EHRs statewide to make it easier to identify fraudulent prescriptions. INSPECT performs two critical functions, officials note. It maintains a warehouse of patient information for healthcare professionals, and it provides a critical investigative tool for law enforcement.

Bass said that if adverse medical events connected to improper use of medication were fewer or eliminated, it would generate significant savings. Moreover, she said, identifying risks for patients who struggle with their medication adherence and adding case management to the equation would help the patients.

“You can go in either direction here,” she said, but both would be extremely beneficial in the future bending of the cost curve.

NEHII partners with the Nebraska Department of Health and Human Services.

“They really are our state partners, and the state has to take the lead with this,” Bass said. “We deliver the technology and perform the work out in the field.”

The state partners are policymakers and administrators of the program, and they also work with NeHII on grant funding, as well as pharmacies and pharmacists.

“They deal on a regular basis with consumers that are asking t questions about medication protocol,” Bass said. “They understand that this can be a very helpful tool for prescribers rather than making frequent phone calls.”

NEHII and the Nebraska Department of Health and Human Services tapped Rockville, Maryland-based DrFirst to capture state prescription information and deliver it to its PDMP.

“NeHII is focused on sharing timely and accurate patient health information in a secure environment to improve patient care,” Bass said. “DrFirst is working closely with us to deliver the functionality we need to further enhance our PDMP, and provide a complete view of a patient’s prescription history and the ability to catch potential red flags, including adverse reactions and opioid abuse.”

There is this list of medications that are deemed “inappropriate” in the elderly

Beers revised: Drugs not to use in older adults

Just watch our “bureaucratic overlords” will use these medication databases and apply the “beliefs” in the Beers Criteria as to what medications many of us are allowed to take… it won’t make any difference if you have been taking them for years and never had any noticeable side effects and/or if side effects that happened with minor in comparison to the benefits of taking one or more medications together.

I have stated before that they are changing the nomenclature that their is no longer any addicts or opiate dependent people… everyone who is taking a opiate legally/illegally is suffering from the disease/condition of “opiate use/abuse disorder”.  Of course, these PMP can’t track someone using a opiate ILLEGALLY, but what about chronic pain pts that pass that 90 day threshold … are these new database going to start throwing RED FLAGS that a particular pt needs to be sent to REHAB ?

Could there be a RED FLAG thrown at the prescriber’s computer.. if there is a record of a benzo or muscle relaxant and opiate prescribed as being taken together and the prescriber’s computer system REFUSE/DENY sending the “offending prescriptions” to a pharmacy to be filled ?

IMO.. these BEERS CRITERIA are not much different than the CDC opiate dosing guidelines…. they are nothing more than guidelines/recommendation for healthcare professionals to be aware that there MAY BE SOME ADVERSE REACTIONS… as we all know… medical care should be individualized and “cookie cutter” treatment plans will not work for all pts.

How far away are we from there only being mostly a need for mid-level healthcare providers ( ARNP, NP, PA, Pharmacist) whose primary purpose is to collect symptoms, enter those into a computer and the artificial intelligence of the computer will produce a plan of treatment.. including medications ?

The Opioid Crisis: An Emerging False Claims Act Risk Trend

https://www.natlawreview.com/article/opioid-crisis-emerging-false-claims-act-risk-trend

The government’s focus on the has been consistently expanding over the past year beyond manufacturers to reach prescribers and health care providers who submit claims to federal health care programs for opioid prescriptions. These efforts increasingly include investigations under the False Claims Act and administrative actions, in addition to the more traditional criminal approach to these issues.

With the Trump administration’s public health emergency orders, it is expected for the government’s enforcement activities, including those instigated by relators and their counsel, to grow in this area.

In Depth

For the past year, we have witnessed increasing governmental focus on the US opioid crisis. Pharmaceutical manufacturers and wholesale distributors have recently seen the most activity with lawsuits filed by almost every state, multiple municipalities and several Native American tribal nations seeking recovery of funds expended dealing with opioid abuse. The federal government, principally the US Department of Justice (DOJ) and the US Department of Health and Human Services Office of Inspector General (OIG), have begun to take actions that indicate their expanding focus on prescribers and health care providers who submit claims to federal health care programs for opioid prescriptions, as well as drug treatment and drug testing services. This activity is taking the form of criminal, civil, and administrative actions and claims audit efforts. With the Trump administration’s public health emergency orders, one can only expect to see the government’s enforcement activities, including those instigated by relators and their counsel, to grow in this area.

Medicare Strikeforce Activities

For years now, DOJ and OIG, with other partner law enforcement agencies, have used the summer months to stage significant orchestrated “takedowns.” This past July’s takedown was the first to feature, as described by OIG, “a large-scale federal and state partnership to combat health care fraud and the opioid epidemic.” This multi-agency, national enforcement operation is described by OIG as the largest in history, both in terms of the number of defendants charged and loss amount. More than 400 defendants in 41 federal districts were charged for their alleged participation in schemes involving more than $1.3 billion in false billings to federal health care programs. Of those subjects charged, 115 are medical professionals, with many of the charges involving improper or excessive prescription of opioids. Exclusion notices were served to 295 individuals (57 doctors, 162 nurses and 36 pharmacists) for conduct related to opioid diversion and abuse. The exclusion notices bar participation in, or submitting claims to Medicare, Medicaid and all other federal health care programs.

DOJ Activities

On January 30, Attorney General Jeff Sessions announced a surge of Drug Enforcement Administration (DEA) agents and investigators over the coming month and a half, focused on pharmacies and prescribers who are dispensing unusual or disproportionate amounts of opioid drugs. The DEA will examine distribution and inventory data reported to the DEA by prescription drug manufacturers and distributors for “patterns” and “outliers” for further investigation.

This follows Attorney General Sessions’ announcement on August 2, 2017, of the creation of the Opioid Fraud and Abuse Detection Unit, a new DOJ pilot program that aims to utilize data to identify physicians and pharmacies for investigation of their opioid prescription practices. This data analytics team is described as tasked with identifying physicians who are “writing opioid prescriptions at a rate that far exceeds their peers; physicians who have patients who died within 60 days of an opioid prescription; the average age of patients receiving these prescriptions; [and] pharmacies that are dispensing disproportionately large amounts of opioids.” As part of the program, DOJ will fund 12 assistant US attorneys for a three-year term to focus solely on investigating and prosecuting health care fraud related to opioid prescribers and pharmacies. These prosecutors will be based in Alabama, California, Florida, Kentucky, Maryland, Michigan, Nevada, North Carolina, Ohio, Pennsylvania, Tennessee and West Virginia.

Prosecutions are not limited to these jurisdictions. From Newark to New Orleans, there has been a noticeable uptick in the number of criminal convictions of physicians and pharmacists for opioid prescription practices. These cases further illustrate the “outlier”-driven approach the government is deploying to identify targets with higher than average prescription and dispensing rates for investigation.

The government’s efforts are also leading to civil cases as well. In 2017, two pharmacies paid $11.75 million and $2.175 million respectively, to settle False Claims Act (FCA) allegations predicated on the Controlled Substances Act, such as filling prescriptions that were incomplete, lacked valid DEA numbers or were for substances beyond various doctors’ scope of practice, and not keeping and maintaining accurate records for controlled substances. There have also been FCA settlements with physicians, clinics, wholesalers and manufacturers concerning opioid prescription issues.

OIG Activities

In addition to the stunningly large number of exclusion notices issued in the July 2017 takedown, OIG is mobilizing its administrative and audit resources to address the opioid crisis. At the American Health Lawyers Association fall conference, Deputy Inspector General for Investigations Gary Cantrell stated that OIG would be evaluating cases for potential civil monetary penalty and exclusion actions in coordination with DOJ’s investigative efforts.

In the same month, OIG issued an unusual “data brief” document discussing its data analysis of Medicare Part D opioid prescriptions. OIG found (1) “one in three Medicare Part D beneficiaries received a prescription opioid in 2016”; (2) about 500,000 beneficiaries (excluding cancer and hospice patients) received high amounts of opioids (defined as an average morphine equivalent dose of greater than 120 milligrams per day or at least three months); (3) almost 90,000 beneficiaries are “at serious risk” who either received “extreme amounts of opioids” or appeared to be doctor shopping; and (4) about 400 prescribers had “questionable opioid prescribing patterns for beneficiaries at serious risk … these patterns are far outside the norm and warrant further scrutiny.” 

For the last four months, OIG has added new items to its audit Work Plan concerning opioids.

In October, OIG added an item to examine the US Food and Drug Administration’s (FDA) use of its the authority to require pharmaceutical companies to develop Risk Evaluation and Mitigation Strategies (REMS) when FDA determines that the risk of using a drug outweighs its benefit. According to OIG, FDA stated it would use the REMS program to “increase the number of prescribers who receive training on pain management and safe prescribing of opioid drugs in order to decrease inappropriate opioid prescribing.” OIG will review how FDA determined the need for opioid REMS and determine the extent to which FDA has held pharmaceutical companies with required opioid REMS accountable for REMS assessments. OIG will also determine the extent to which FDA has held opioid REMS sponsors accountable for REMS goals to mitigate risks of misuse, abuse, addiction, overdose and serious complications because of medication errors. This audit topic may spur FDA to increase the use of, and scrutiny of existing, REMS programs.

  • In November, OIG said it would conduct an analysis of Medicaid beneficiaries to, similar to the Medicare Part D data brief, identify beneficiaries who received extreme amounts of opioids through Medicaid and those cases that appear to involve doctor shopping or pharmacy shopping, as well as prescribers associated with these beneficiaries.
  • In December, OIG announced an audit of states’ use of funding from the Centers for Disease Control and the Substance Abuse and Mental Health Services Administration (SAMHSA) to prevent opioid abuse and misuse. This audit could spur certain states to increase their activities, which could include detecting suspect Medicaid spending on controlled substances.
  • Also in December, OIG announced an audit of technology/information security (IT/IS) operations and opioid prescribing practices at five Indian Health Services (IHS) hospitals to determine whether (1) IHS’s decentralized management structure has affected its ability to deliver adequate IT/IS services in accordance with federal requirements, and (2) hospitals prescribed and dispensed opioids in accordance with IHS policies and procedures. This audit topic may be of interest to health systems, physician practices and pharmacies as a step to take to monitor a facet of their opioid dispending patterns and controls.
  • In January, OIG stated plans to release a toolkit as a follow up to the data brief “to assist public and private stakeholders in addressing the opioid epidemic.” The toolkit will provide information on how OIG analyzed a large dataset of opioid claims to produce patient-level opioid data, as well as how it calculated Morphine Equivalent Dose (MED) levels for these patients. This toolkit could be a valuable resource for providers to analyze their own prescriber data, as well as provide relators’ counsel and prosecutors with similar abilities.

Attention to the opioid crisis shows no signs of decreasing. Various government agencies are devoting substantial resources to addressing opioid abuse, including investigating and pursuing prescribers, health care providers and manufacturers. Organizations should consider the extent to which opioid prescription issues and practices are addressed by the compliance programs’ risk assessment and auditing and monitoring functions. 

If a doctor stops a pt’s opiate therapy… is this an admission that the prescriber has been providing – and charging insurance for – unnecessary medical services ? Should the pt file a complaint with the Medicare/Medicaid OIG office under the False Claim Act ?

it is very unusual that a opiate dependent chronic pain pt is healed to a point where they no longer need opiate therapy.  So if a prescriber is stopping a chronic pain pt’s opiate therapy… not necessarily because they are no longer in pain … but for some other reason… could all the time that the prescriber treated the pt for chronic pain and submitted bills to insurance be considered fraudulent  ?  And if a prescriber is doing this on all of his/her pts then there could be the possibility of a gross amount of fraudulent billing mounting into maybe HUNDREDS OF THOUSANDS OF DOLLARS…

Healthcare professionals seem to state over and over that they are protecting their licenses and the pt’s quality of life, well being, even their ability to function at some degree of “normal” or at least their previous “normal”.  At what point was the prescriber treating/charging for pt care that was no longer necessary?

The other side of the OPIOID CRISIS

 

Forfeiture Support Associates: Data Analyst Supporting the DEA

Data Analyst Supporting the DEA

Forfeiture Support Associates – Washington, DC

Glassdoor Estimated Salary: $48k-$81k
  • Job
  • Company
  • Rating
  • Reviews
Salary: 25.29

Published Job Title:

Data Analyst Supporting the DEA

Requisition::
18-32

Worksite::
DEA

Position Schedule::
Full-time

Description::

Focused on delivering unsurpassed services in support of the increased demand for law enforcement and homeland security, FSA, a rapidly growing joint venture owned by trusted solutions providers Engility and AECOM, has a vacancy for a Data Analyst supporting the DEA.
A Data Analyst executes the following duties:
  • Provide organization and management of case files
  • Review data (completeness of information, proper execution)
  • Extract data from data base

  • Obtain additional information from other investigative agencies/data base

  • Establish/maintain physical file
  • Prepare notices/advertisements
  • Receive, suspense petitions, claims, process sharing requests
  • Reconcile inconsistencies
  • Prepare declarations
  • Gather information and organize investigative package

  • Verify case files and case tracking system
  • Maintain internal status information on the disposition of all forfeited assets

  • Assure information is accurate and perform analytical computations necessary to process data
  • Conduct and reconcile inventories

  • Distribute and receive documents
  • Assist lead analyst or official in obtaining/collecting all documents/information to complete case file

  • Provide administrative information and assistance concerning case to other investigative agencies, local law enforcement agencies, US Attorney, and other DOJ processing units, and higher headquarters
  • Extract data from agency data base for management and program reports

  • Perform word processing relevant to case documentation
  • Perform data entry relevant to case

Requirements::

A Data Analyst must meet the following qualifications:
  • High School diploma, bachelor’s Degree preferred
  • Ability to review and analyze data and information from multiple sources
  • Ability to establish case/project files
  • Ability to enter and retrieve data from data bases
  • Ability to prepare and format management reports
  • Ability to manipulate, transfer, and compute and print information

  • Ability to create and manipulate spreadsheets

  • Ability to prepare and correct reports and correspondence using word processing software
This position requires U.S. Citizenship and a 7 (or 10) year minimum background investigation.

EEO Statement:
Forfeiture Support Associates (FSA) LLC is proud to be an Affirmative Action/ Equal Opportunity Employer. We recruit, employ, train, compensate, and promote qualified persons in all job titles without regard to age, ancestry, color, gender, HIV status, marital status, medical condition, national origin, physical or mental disability, race, religion, sex, sexual orientation (including gender expression and identity) veteran status, family leave status, and any protected group status as defined by applicable law.

why do we have doctors when insurance companies seem to insist on practice medicine and the FINAL AUTHORITY ?

My name is xxxx.xxxxx & I have been on disability since 2005 due to chronic pain brought on by Degenerative Disc Disease, failed Lumbar Surgery, progressive spinal disc bulging and stenosis in both my Lumbar and Cervical spine, and Fibromyalgia. I have been on MS-Contin (100mg 3 times daily) for over 5 years and prior to this medication, I took meds that were just as strong, if not stronger. I also suffer from depression, generalized anxiety disorder, panic attacks, and Restless Leg Syndrome (which affects not only my legs, but my entire body), and within the last year I have developed seizures. I am currently in the testing process to see what is causing the seizures. I have had an MRI of my brain and it shows lesions in my frontal lobe. I have an appointment with a neurologist, but could not get in to see one until April 2nd. Due to the above conditions, I also take Alprazolam (Xanax–1mg twice daily as needed). I have been taking this medication on and off for well over 15 years for the anxiety disorder, panic attacks & restless leg/body syndrome. I have also found that if I take one as I feel a seizure coming on, it helps me to relax & makes for a smoother transition after the seizure passes. I am not in as much pain because I have not tensed up as much as I would normally have done if I had not taken the Xanax. It also shortens the seizure and nothing else has helped me except for the Xanax since these strange seizures have started. My Xanax is  prescribed by my psychiatrist, a completely different doctor than the one who prescribes my MS-Continue. My pain management doctor prescribes the MS-Contin. My dilemma is this:  After having Blue Cross & Blue Shield Federal Employee Health Insurance Basic Health Care & Pharmacy Program since 1/1/2008 & being prescribed these two medications together for most of that time, the Pharmacist at BCBS who’s in charge of my medications has denied my prescription for MS-Contin because I also take Xanax & this Pharmacist & the BCBS program has decided that I can’t take both of them together because it’s too dangerous. Mind you, they didn’t deny the much less expensive Alprazolam, which I could probably buy without the help of insurance for less than $20 per month, they’ve denied the Morphine Sulfate ER 100Mg (qty of 84 per month), which I now must pay (out of pocket) $170.00 per month! My pain management doctor tried to appeal this ruling & I was denied for a second time. Do you have any advice for me? Do I have any legal recourse over Blue Cross? If I start paying for my Xanax without using insurance will Blue Cross still know I’m getting it & continue to deny paying for my MS-Contin? I truly do need both of these medications! I’m not one of those drug shoppers who doctor shop trying to find places to get prescriptions for pain pills! I am truly in need! I had an appointment yesterday with a spine specialist because I have lesions on my spine that have grown since my last MRI & he is sending me for a bone scan & a CT scan. He told me, after looking at my MRI film, not to let any surgeon talk me into surgery because my spine is so bad that no amount of surgery will ever fix me. My only option is to live the rest of my life under the care of a caring Pain Management Physician who will prescribe the necessary medications to keep me as pain free as humanly possible & once I find a combination of meds that work for me I should stay the course and follow my doctor’s orders! How am I supposed to do that when my insurance company thinks they know me better than my doctor does? I thought I lived in America, but it’s starting to feel less like America and more like Russia or China. 

Is this just a way for the insurance company to SAVE MONEY by denying a pt their necessary medication by using very poor clinical data to justify their decision or they setting the pt up for some problems because the DEA considers it a RED FLAG for a pt to pay cash for a controlled substance when they have insurance… probably doesn’t make any difference to the DEA bureaucracy that the pt’s insurance won’t pay for the medication ?

Apparently BS/BS Federal has appoint a Pharmacist who doesn’t have prescriptive authority – to make medical decision probably based on some academic studies that suggests that there is the POTENTIAL for serious medication interaction… However, many of these academic studies have been concluded by what addicts have done in the past and had “bad outcomes”… In this particular incident, the pt had been taking the two medications for several years without any adverse events… so – IMO – anyone making a decision based on some academic data, that did not come from similar situations… is highly inappropriate and will adversely affect the pt’s quality of life.

Since these types of issues are literately EXPLODING… there is one avenue of action that these self-appointed medical experts may not even expect.  If the decisions and actions of these entities cause the pt’s quality of life (QOL) goes in the crapper and the pt becomes house, chair,bed confined… there is a possibility of suing for https://www.legalmatch.com/law-library/article/limits-on-damages-for-loss-of-society-companionship–consortium.html 

They will be expecting law suits for MAL PRACTICE but not being sued by the spouse and family…  In this particular case, being the insurer of Federal employees there is probably hundreds or thousands of other pts in the same situation… which could be the basis of a class action.  Attorneys look for large number of people harmed and “deep pockets” from the entity that caused it.